Anticancer Drug Protection in Neurodegenerative Disorders a Medication Repurposing Approach
Received Date: Aug 30, 2023 / Published Date: Oct 31, 2023
Abstract
Neurodegenerative disorders and cancer, though seemingly disparate, share underlying cellular and molecular mechanisms, including aberrant cell proliferation and programmed cell death. This convergence provides a unique opportunity for medication repurposing, where existing anticancer drugs may find a new role in mitigating neurodegenerative diseases. This review explores the potential of repurposing anticancer drugs as a novel therapeutic approach for neurodegenerative disorders. We delve into the commonalities between these seemingly distinct pathologies and discuss the promise, challenges, and future directions in harnessing the anticancer potential for neuroprotection.
Citation: Kumar P (2023) Anticancer Drug Protection in NeurodegenerativeDisorders a Medication Repurposing Approach. J Pharmacokinet Exp Ther 7: 196. Doi: 10.4172/jpet.1000196
Copyright: © 2023 Kumar P. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
黑料网 Journals
Article Tools
Article Usage
- Total views: 489
- [From(publication date): 0-2023 - Nov 23, 2024]
- Breakdown by view type
- HTML page views: 423
- PDF downloads: 66
